Anti-inflammatory properties of kefir and its polysaccharide extract

Inflammopharmacology

Volumn 13, Issue 5-6, 2005, Pages 485-492

  Rodrigues, K L ^a   Carvalho, J C T ^a   Schneedorf, J M ^a  

^a Unifenas   (Brazil)

Author keywords

Inflammation; Kefir; Kefiran; Prebiotic; Probiotic

Indexed keywords

ANTIINFLAMMATORY AGENT; CARRAGEENAN; DEXTRAN; HISTAMINE; KEFIRAN; MOLASSES; POLYSACCHARIDE; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; COTTON; FEMALE; FERMENTED PRODUCT; GRAIN; GRANULOMA; ISOLATION PROCEDURE; KEFIR; MALE; MILK; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; THAWING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CULTURED MILK PRODUCTS; FEMALE; MALE; POLYSACCHARIDES; PROBIOTICS; RATS; RATS, WISTAR;

EID: 28844497408     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856005774649395     Document Type: Article

References (16)

1. Bohmler, G., Gerwert, J., Scupin, E., et al. (1996). The epidemiology of helicobacteriosis in humans; studies of the survival capacity of the microbe in food, Dtsch. Tierarztl. Wochenschr. 103, 438-443.
2. Cardoso, L. V. G., Ferreira, M., Schneedorf, J. M., et al. (2003). Avaliação de fermentdo de quefir sobre o trânsito intestinal de ratos, J. Bras. Fitomed. 1, 107-109 (in Portugese).
3. Carvalho, J. C. T. (1998). Validação química- farmacológica da espécie vegetal Pterodon emarginatus VOG. (Atividade anti-inflamatória). Thesis, Universidade de São Paulo, São Paulo (in Portugese).
4. Carvalho, J. C. T., Sertié, J. A. A., Barbosa, M. V. J., et al. (1999). Anti-inflammatory activity of the crude extract from the fruits of Pterodon emarginatus Vog, J. Ethnopharmacol. 64, 127-133.
5. DiRosa, M., Giroud, J. P. and Willoughby, D. A. (1971). Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine, J. Pathol. 104, 15-29.
6. Ferreira, S. H., Moncada, S. and Vane, J. R. (1973). Some effects of inhibiting endogenous prostaglandin formation on the responses of the cat spleen, Br. J. Pharmacol. 47, 48-58.
7. Hallé, C., Leroi, F., Dousset, X., et al. (1994). Les kéfirs: des associations bactéries lactiques-levures, in: Bactéries lactiques: aspects fondamentaus et technologiques, vol. 2, De Roissart, H. and Luquet, F. M. (Eds), pp. 169-182. Lorica, Uriage (in French).
8. Liu, J. R., Chen, M. J. and Lin, C. W. (2005). Antimutagenic and antioxidant properties of milk-kefir and soymilk-kefir, J. Agric. Food Chem. 53, 2467-2474.
9. Meier, R., Schuler, W. and Desaulles, P. (1950). Zur Frage des Mechanismus der Hemmung des Bindegewebswachstums durch Cortisone, Experientia 6, 469-471 (in German).
10. Micheli, L., Uccelletti, D., Palleschi, C., et al. (1999). Isolation and characterisation of a ropy Lactobacillus strain producing the exopolysaccharide kefiran, Appl. Microbiol. Biotechnol. 53, 69-74.
11. Osada, K., Nagira, K., Teruya, K., et al. (1993). Enhancement of interferon-beta production with sphingomyelin from fermented milk, Biotherapy 7, 115-123.
12. Ota, A. (1999). Protection against an infection disease by enterohaemorragic E. coli 0-157, Med. Hypothes. 53, 87-88.
13. Rodrigues, K. L., Caputo, L. R., Carvalho, J. C. T., et al. (2005). Antimicrobial and healing activity of kefir and kefiran extract, Int. J. Antimicrob. Agents 25, 404-408.
14. Rowley, D. A. and Benditt, E. P. (1956). 5-Hydroxytryptamine and histamine as mediators of the vascular impury produced by agents which damage mast cells in rats, J. Exp. Med. 103, 399-415.
15. Schneedorf, J. M. and Anfiteatro, D. (2004). Quefir, um probiótico produzido por microorganismos encapsulados e inflamação, in: Fitoterápicos anti-inflamatórios aspectos químicos, farmacológicos e aplicações terapêuticas, Carvalho, J. C. T. (Ed.), ch. 33, pp. 443-467. Tecmedd, Ribeirão Preto.
16. Van Arman, C. G., Begany, A. J., Miller, I. M., et al. (1965). Some details of the inflammation caused by yeast and carrageenan (with appendix on kinetics of the reaction), J. Pharmacol. Exp. Ther. 150, 328-334.